SINT - Sintx Technologies, Inc.

Insider Purchase by Honigblum Gregg R. (Chief Investment Officer)

3 Months
After Trade
Before Trade

Loading data...

Trade Summary

2 months ago, Honigblum Gregg R., serving as Chief Investment Officer at Sintx Technologies, Inc. (SINT), purchased 65,000 shares at $3.93 per share, for a total transaction value of $255,350.00. Following this transaction, Honigblum Gregg R. now holds 192,867 shares of SINT.

This purchase represents a 51.00% increase in Honigblum Gregg R.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, December 5, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 8, 2025, 3 days after the trade was made.

Sintx Technologies, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Honigblum Gregg R.

Chief Investment Officer

Gregg R. Honigblum is the Chief Investment Officer and Director at SINTX Technologies, Inc. (NASDAQ: SINT), a position he has held since April 2025.[[6]](https://simplywall.st/stocks/us/healthcare/nasdaq-sint/sintx-technologies/management)[[8]](https://sintx.com/about/executive-team-and-board-of-directors/) He also serves as a 10% Owner of the company and has a board tenure of 18.8 years, indicating long-term involvement with the organization.[[2]](https://www.tradingview.com/news/tradingview:a11e65868b34a:0-sintx-technologies-director-gregg-r-honigblum-acquires-8-200-shares/)[[6]](https://simplywall.st/stocks/us/healthcare/nasdaq-sint/sintx-technologies/management) Honigblum recently acquired common shares, including 8,200 shares on December 8, 2025, and 10,000 shares in November 2025, reflecting confidence in the company's prospects.[[2]](https://www.tradingview.com/news/tradingview:a11e65868b34a:0-sintx-technologies-director-gregg-r-honigblum-acquires-8-200-shares/)[[4]](https://www.investing.com/news/insider-trading-news/honigblum-sintx-technologies-chief-investment-officer-buys-31900-in-stock-93CH-4345863) With over 35 years of experience as an executive in emerging growth companies, particularly in the healthcare sector, Honigblum was appointed Chief Strategy Officer prior to his current role.[[7]](https://www.globenewswire.com/news-release/2024/11/19/2983389/30038/en/SINTX-Technologies-Appoints-Gregg-R-Honigblum-as-Chief-Strategy-Officer.html) His 2025 compensation as Chief Investment Officer and Director was approximately US$34.35k, with personal ownership valued at 1.78% or about $253.4k.[[6]](https://simplywall.st/stocks/us/healthcare/nasdaq-sint/sintx-technologies/management)

View full insider profile →

Trade Price

$3.93

Quantity

65,000

Total Value

$255,350.00

Shares Owned

192,867

Trade Date

Friday, December 5, 2025

79 days ago

SEC Filing Date

Monday, December 8, 2025

Filed 3 days after trade

HEALTHCAREMEDICAL DEVICES

About Sintx Technologies, Inc.

Company Overview

No company information available
View news mentioning SINT

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/2050189

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime